Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Diabetes|August 27, 2015
Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney DiseaseJennifer N Todd, Emma H Dahlström, Rany M Salem, et al.
European Journal of Medicinal Chemistry|November 13, 2018
Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A<sub>4</sub> mimetics (sLXms)Monica de Gaetano, Eibhlín Butler, Kevin Gahan, et al.
Journal of Medicinal Chemistry|June 17, 2021
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A<sub>4</sub> Mimetics (QNX-sLXms)Monica de Gaetano, Catherine Tighe, Kevin Gahan, et al.
Circulation Research|October 1, 2025
Macrophage DNases Limit Neutrophil Extracellular Trap-Mediated Defective Efferocytosis in AtherosclerosisUmesh Kumar Dhawan, Tanwi Vartak, Hanna Englert, et al.
Diabetes|February 18, 2026
Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney DiseaseMadhura Bose, Muthukumar Mohan, Jun Okabe, et al.
Circulation Research|November 4, 2025
TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in AtherosclerosisAarushi Singhal, Stefan Russo, Umesh Kumar Dhawan, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 30, 2024
Treatment with lipoxin A<sub>4</sub> improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responsesFlavia Rago, Eliza Mathias Melo, Leigh M Miller, et al.
Pageof 4